T1	PROC 48 94	Estudio de extensión intervencionista, abierto
T2	CHEM 118 129	aripiprazol
#1	AnnotatorNotes T2	C0299792; aripiprazole; Organic Chemical · Pharmacologic Substance
T3	DISO 175 188	esquizofrenia
#2	AnnotatorNotes T3	C0036341; Schizophrenia; Mental or Behavioral Dysfunction
T4	DISO 212 225	Esquizofrenia
#3	AnnotatorNotes T4	C0036341; Schizophrenia; Mental or Behavioral Dysfunction
T5	PROC 278 289	tratamiento
#4	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	CHEM 294 305	aripiprazol
#5	AnnotatorNotes T6	C0299792; aripiprazole; Organic Chemical · Pharmacologic Substance
T7	PROC 424 435	tratamiento
#6	AnnotatorNotes T7	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T8	CHEM 454 465	aripiprazol
#7	AnnotatorNotes T8	C0299792; aripiprazole; Organic Chemical · Pharmacologic Substance
T9	PROC 542 566	consentimiento informado
#8	AnnotatorNotes T9	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T10	PROC 615 639	consentimiento informado
#9	AnnotatorNotes T10	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T11	PROC 661 681	estudio de extensión
T12	DISO 768 790	trastorno psiquiátrico
#10	AnnotatorNotes T12	C0004936; Mental disorders; Mental or Behavioral Dysfunction
T13	PROC 751 764	diagnosticado
#11	AnnotatorNotes T13	C0011900; Diagnosis; Diagnostic Procedure
T14	DISO 803 816	esquizofrenia
#12	AnnotatorNotes T14	C0036341; Schizophrenia; Mental or Behavioral Dysfunction
T15	DISO 923 931	suicidio
#13	AnnotatorNotes T15	C0038661; Suicide; Finding
T16	DISO 1031 1047	Ideación suicida
#14	AnnotatorNotes T16	C0424000; Feeling suicidal (finding); Finding
T17	DISO 1118 1134	Conducta suicida
#15	AnnotatorNotes T17	C1760428; Suicidal behavior; Finding
T18	DISO 1163 1185	acontecimiento adverso
#16	AnnotatorNotes T18	C0877248; Adverse event; Pathologic Function
T19	Date 12 16	2012
T20	Frequency 143 157	una vez al mes
T21	LIVB 161 170	pacientes
#17	AnnotatorNotes T21	C0030705; Patients; Patient or Disabled Group
T22	LIVB 257 265	paciente
#18	AnnotatorNotes T22	C0030705; Patients; Patient or Disabled Group
T23	Frequency 306 320	una vez al mes
T24	LIVB 374 386	investigador
#19	AnnotatorNotes T24	C0035173; Research Personnel; Professional or Occupational Group
T25	LIVB 391 399	paciente
#20	AnnotatorNotes T25	C0030705; Patients; Patient or Disabled Group
T26	Duration 439 449	24 semanas
T27	Frequency 466 480	una vez al mes
T28	LIVB 487 495	paciente
#21	AnnotatorNotes T28	C0030705; Patients; Patient or Disabled Group
T29	LIVB 573 581	paciente
#22	AnnotatorNotes T29	C0030705; Patients; Patient or Disabled Group
T30	LIVB 733 741	paciente
#23	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T31	LIVB 861 873	investigador
#24	AnnotatorNotes T31	C0035173; Research Personnel; Professional or Occupational Group
T32	LIVB 878 886	paciente
#25	AnnotatorNotes T32	C0030705; Patients; Patient or Disabled Group
T34	LIVB 1142 1150	paciente
#26	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group
T35	LIVB 1262 1274	investigador
#27	AnnotatorNotes T35	C0035173; Research Personnel; Professional or Occupational Group
T37	PHYS 1031 1039	Ideación
#28	AnnotatorNotes T37	C0392348; ideation; Mental Process
T38	Dose 100 114	dosis flexible
T39	Spec_cue 899 905	riesgo
T33	Date 1204 1212	en curso
T36	PHYS 515 525	comprender
#29	AnnotatorNotes T36	C0162340; Comprehension; Mental Process
T40	PHYS 508 512	leer
#30	AnnotatorNotes T40	C2372013; Reading; Mental Process
T41	Neg_cue 791 802	distinto de
T42	Quantifier_or_Qualifier 964 969	basal
T43	PROC 957 963	visita
#31	AnnotatorNotes T43	C1512346; Patient Visit; Health Care Activity
A1	Assertion T15 Speculated
A2	Assertion T14 Negated
#32	AnnotatorNotes T42	C1442488; Baseline; Quantitative Concept
T44	Quantifier_or_Qualifier 970 972	II
T45	Spec_cue 1288 1295	posible
T46	Observation 1296 1320	riesgo para la seguridad
A3	Assertion T46 Speculated
T47	Spec_cue 400 409	obtendría
T48	Observation 410 419	beneficio
A4	Assertion T48 Speculated
#33	AnnotatorNotes T48	C4049461; Unexpected beneficial therapeutic response; Finding (?)
R1	Speculation Arg1:T47 Arg2:T48	
R2	Before Arg1:T7 Arg2:T48	
R3	Has_Duration_or_Interval Arg1:T7 Arg2:T26	
R4	Used_for Arg1:T8 Arg2:T7	
R5	Has_Dose_or_Strength Arg1:T2 Arg2:T38	
R6	Has_Frequency Arg1:T2 Arg2:T20	
R7	Experiences Arg1:T21 Arg2:T3	
R8	Experiences Arg1:T21 Arg2:T2	
R9	Experiences Arg1:T22 Arg2:T5	
R10	Used_for Arg1:T6 Arg2:T5	
T49	Observation 326 347	completado el estudio
#34	AnnotatorNotes T49	C2732579; Completion of clinical trial; Finding
R12	Has_Frequency Arg1:T6 Arg2:T23	
R13	Experiences Arg1:T25 Arg2:T48	
R14	Has_Frequency Arg1:T8 Arg2:T27	
R15	Experiences Arg1:T25 Arg2:T7	
R16	Experiences Arg1:T28 Arg2:T40	
R17	Experiences Arg1:T28 Arg2:T36	
R18	Overlap Arg1:T36 Arg2:T9	
R19	Overlap Arg1:T40 Arg2:T9	
R20	Before Arg1:T10 Arg2:T11	
R21	Experiences Arg1:T30 Arg2:T12	
R22	Experiences Arg1:T30 Arg2:T14	
R23	Negation Arg1:T41 Arg2:T14	
T50	PROC 828 835	estudio
R24	Overlap Arg1:T12 Arg2:T50	
R25	Overlap Arg1:T14 Arg2:T50	
#35	AnnotatorNotes T50	C0008976; Clinical Trials; Research Activity
R26	Experiences Arg1:T32 Arg2:T15	
T51	Observation 899 922	riesgo significativo de
#36	AnnotatorNotes T51	C0332167; High risk of; Finding
R27	Before Arg1:T51 Arg2:T15	
R28	Experiences Arg1:T32 Arg2:T51	
R29	Speculation Arg1:T39 Arg2:T15	
R30	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T42	
R31	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T44	
T52	CONC 944 950	C-SSRS
#37	AnnotatorNotes T52	C3888485; Columbia Suicide Severity Rating Scale; Intellectual Product
R32	Overlap Arg1:T52 Arg2:T43	
R34	Experiences Arg1:T34 Arg2:T18	
R35	Overlap Arg1:T18 Arg2:T33	
T53	CHEM 1232 1235	IMP
#38	AnnotatorNotes T53	C0013230; Investigational New Drugs; Pharmacologic Substance (?) ['investigational medicinal product']
R36	Causes Arg1:T53 Arg2:T18	
R37	Speculation Arg1:T45 Arg2:T46	
R38	Before Arg1:T53 Arg2:T46	
R39	Experiences Arg1:T34 Arg2:T46	
R11	Experiences Arg1:T32 Arg2:T43	
#39	AnnotatorNotes T33	C0521116; Current (present time); Temporal Concept
A5	Assertion T52 Hypothetical
A6	Assertion T43 Hypothetical
A7	Assertion T42 Hypothetical
A8	Assertion T44 Hypothetical
A9	Experiencer T21 Patient
A10	Experiencer T22 Patient
A11	Experiencer T24 Other
A12	Experiencer T25 Patient
A13	Experiencer T28 Patient
A14	Experiencer T29 Patient
A15	Experiencer T30 Patient
A16	Experiencer T31 Other
A17	Experiencer T32 Patient
A18	Experiencer T34 Patient
A19	Experiencer T35 Other
T54	Quantifier_or_Qualifier 1186 1203	moderado o severo
#40	AnnotatorNotes T54	C1299393; Moderate to severe; Qualitative Concept
R33	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T54	
